Peptide based enzyme-linked immunoassays for detection of anti-HSV-2 IgG in human sera

Journal of Virological Methods

Volumn 87, Issue 1-2, 2000, Pages 63-70

  Oladepo, D K ^a   Klapper, P E ^b   Marsden, H S ^c  

^a Newtech Sq Deeside Indust Pk C ^*  (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Cross reactivity; EIA; Glycoprotein G2; Peptide 55; Serology

Indexed keywords

IMMUNOGLOBULIN G; PROTEIN P55; THROMBOSPONDIN;

ARTICLE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DNA SEQUENCE; ELECTROIMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; HUMAN; METHODOLOGY; PRIORITY JOURNAL; SERODIAGNOSIS; SEROLOGY;

ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CROSS REACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE REACTIONS; GLYCOPROTEINS; HERPES SIMPLEX; HERPESVIRUS 2, HUMAN; HUMANS; IMMUNODOMINANT EPITOPES; IMMUNOGLOBULIN G; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS;

HSV 2; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 2;

EID: 0034129434     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-0934(00)00152-X     Document Type: Article

References (36)

1. Ashley R.L., Militoni J., Lee F. et al. Comparison of Western Blot (Immunoblot) and glycoprotein g-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera. J. Clin. Microbiol. 26(4):1988;662-667.
2. Ashley R.L., Cent A., Mages V. et al. Inability of enzyme immunoassay to discriminate between infections with herpes simplex types1 and 2. Ann. Int. Med. 115:1991;520-526.
3. Ashley R.L., Wu L., Pickering J.W. et al. Premarket evaluation of a commercial glycoprotein g-based enzyme immunoassay for herpes simplex virus type-specific antibodies. J. Clin. Microbiol. 36:1998;294-295.
4. Boucher F.D., Yasukawa L.Y., Kerns K. et al. Detection of antibodies to herpes simplex virus type 2 with mammalian cell line expressing glycoprotein gG2. Clin. Diag. Virol. 1:1993;29-38.
5. Brown Z.A., Selke S., Zeh J. et al. The acquisition of herpes simplex virus during pregnancy. N. Engl. J. Med. 337(8):1997;509-515.
6. Corey I. The current trend in genital herpes. Progress in prevention. Sex. Trans. Diseases. 21(Suppl. 2):1994;S38-S44.
7. Cowan F.M., Johnson A.M., Ashley R. et al. Relationship between antibodies to herpes simplex virus types 2 (HSV) and sypmtons of HSV infection. J. Infect. Diseases. 174:1996;470-475.
8. Eis-Hubinger A.M., Kleim J.P., Mohr K. et al. A related epitope is consistently present on glycoprotein C of herpes simplex virus types 1 and 2. Acta Virol. 35:1991;276-281.
9. Fleming D.T., McQuillan G.M., Johnson R.E. Herpes simplex type 2 in the US, 1976-1994. New Engl. J. Med. 337:1997;1105-1556.
10. Hashido M., Lee F.K., Inouye S. et al. Detection of herpes simplex virus type-specific antibodies by an enzyme-linked immunosorbent assay based on glycoprotein G. J. Med. Virol. 53:1997;319-323.
11. Ho D.W.T., Field P.R., Sjogren-Jansson E. et al. Indirect ELISA for the detection of HSV-2 specific IgG and IgM antibodies with glycoprotein G (gG-2). J. Virol. Methods. 26:1992;249-264.
12. Hook E.W., Cannon R.O., Nahmias A.J. et al. Herpes simplex virus infection as a risk factor for HIV infection in heterosexuals. J. Infect. Diseases. 165:1992;251-255.
13. Koelle D.M., Benedetti J., Langenberg A. et al. Asymptomatic reactivation of herpes simplex virus in women after first episode of genital herpes. Ann. Int. Med. 116:1992;433-437.
14. Langenberg A.G.M., Corey L., Ashley R.L. et al. A prospective study of new infections with herpes simplex virus type 1 and type 2. New Engl. J. Med. 341(19):1999;1432-1438.
15. Lee F.K., Coleman R.M., Pereira L. et al. Detection of herpes simplex virus type 2-specific antibody with glycoprotein G. J. Clin. Microbiol. 22(4):1985;641-644.
16. Lee F.K., Pereira L., Griffin C. et al. A novel glycoprotein for detection of herpes simplex virus type 1-specific antibodies. J. Virol. Methods. 14:1986;111-118.
17. Levi M., Ruden U., Wahren B. Peptide sequences of glycoprotein G-2 discriminate between herpes simplex virus type 2 (HSV-2) and HSV-1 antibodies. Clin. Diag. Lab. Immunol. 3:1996;265-269.
18. Liljeqvist J., Trybala E., Svennerholm B. et al. Localisation of type-specific epitopes of herpes simplex virus type 2 glycoprotein G recognised by human and mouse antibodies. J. Gen. Virol. 79:1998;1215-1224.
19. Marsden H.S., Buckmaster A., Palfreyman J.W. et al. Characterization of the 92 000-Da glycoprotein induced by herpes simplex virus type 2. J. Virol. 50:1984;547-554.
20. Marsden H.S., Owsianka A.M., Graham S. et al. Advantages of branched peptides in serodiagnosis: detection of HIV-specific antibodies and the use of glycine spacers to increase sensitivity. J. Immunol. Methods. 147:1992;65-72.
21. Marsden H.S., MacAulay K., Murray J. et al. Identification of an immunodominant sequential epitope in glycoprotein G of herpes simplex virus type 2 that is useful for serotype-specific diagnosis. J. Med. Virol. 56:1998;79-84.
22. McGeoch D.J., Dolan S., Rixon F.J. Sequence determination and genetic content of the short unique region in the genome of herpes simplex virus type 1. J. Mol. Biol. 181:1985;1-13.
23. McGeoch D.J., Moss H.W.M., McNab D. DNA sequence and genetic content of the HindIII region in the short unique component of the herpes simplex virus type 2 genome: identification of the gene encoding glycoprotein G, and evolutionary comparisons. J. Gen. Virol. 68:1987;19-38.
24. Parkes D.L., Smith C.M., Rose J.M. et al. Seroreactive recombinant herpes simplex virus type 2-specific glycoprotein G. J. Clin. Microbiol. 29:1991;778-781.
25. Roizman B., Norrid B., Chan C. et al. Identification and preliminary mapping with monoclonal antibodies of a herpes simplex virus type 2 glycoprotein lacking a known type-1 counterpart. Virology. 133:1984;242-247.
26. Sanchez-Martinez D., Schmid S., Whittington W. et al. Evaluation of a test based on baculovirus-expressed glycoprotein G for detection of herpes simplex virus type-specific antibodies. J. Infect. Diseases. 164:1991;1196-1199.
27. Schmid D.S., Brown D.R., Nisenbaum R. et al. Limits in reliability of glycoprotein G-based type-specific serologic assays for herpes simplex virus types 1 and 2. J. Clin. Microbiol. 37(2):1999;376-379.
28. Smith I.W., Peutherer J.F., MacCallum F.O. The incidence of herpes virus hominis antibody in the population. J. Hygiene. 65:1967;395-408.
29. Stamm W.E., Handsfield H.H., Rompalo A.M. Association between genital ulcer disease and acquisition of HIV infection in heterosexuals men. J. Am. Med. Ass. 260:1988;1429-1433.
30. Sullender W.M., Yasukawa L.L., Schwartz M. et al. Type-specific antibodies to herpes simplex virus type 2 (HSV-2) glycoprotein G in pregnant women, infants exposed to maternal HSV-2 infections at delivery, and infants with neonatal herpes. J. Infect. Diseases. 157:1991;164-171.
31. Svennerholm B., Olofsson S., Jeansson S. et al. Herpes simplex virus type-selective enzyme-linked immunosorbent assay with Helix pomatia lectin-purified antigens. J. Clin. Microbiol. 19:1984;235-239.
32. Tam J.P. Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system. Proc. Natl. Acad. Sci. USA. 85:1988;5409-5413.
33. Trybala E., Bergstrom T., Olofsson S. et al. An evaluation of a hemagglutination-inhibition test for the detection of antibodies to herpes simplex virus type 1. Clin. Diag. Virol. 3:1995;191-220.
34. Wald A.J.Z., Barnum G. Suppression of subclinical shedding of herpes simplex virus type 2 with acyclovir. Ann. Int. Med. 124:1996;8-15.
35. Whitley R.J., Nahmias A.J., Visintine A.M. et al. The natural history of herpes simplex virus infection of mother and newborn. Pediatrics. 66:1996;189-194.
36. WHO Workshop, 1995. Epidemiology of herpes simplex virus infections and surveillance of other sexually transmitted diseases in Europe. Copenhagen, Denmark.